Literature DB >> 12034046

Regulation of eosinophil-active cytokine production from human cord blood-derived mast cells.

Guha Krishnaswamy1, Kenton Hall, George Youngberg, Fred Hossler, David Johnson, William A Block, Shau-Ku Huang, Jim Kelley, David S Chi.   

Abstract

Human mast cells are multifunctional tissue-dwelling cells that play a crucial role in eosinophil-dependent disorders, such as asthma and parasitic diseases, by the secretion of eosinophil-active mediators. Mast cell-derived cytokines, generated in response to cross-linking of the high-affinity IgE receptor, can regulate eosinophil activation, survival, and chemotaxis. In this study, mast cells generated from human cord blood progenitors (stem cells) were studied for eosinophil-active inflammatory cytokine expression. Cord blood-derived mast cells (CBDMC) expressed typical intracellular scroll granules and microvilli-like structures on their cell surfaces, demonstrated the presence of tryptase, and elaborated prostaglandin D2 (PGD2) after cross-linkage of the high-affinity receptor for IgE (FcepsilonRI). CBDMC expressed tumor necrosis factor-alpha (TNF-alpha) and the eosinophil-active growth factors, interleukin-5 (IL-5) and granulocyte-macrophage colony-stimulating factor (GM-CSF) after activation. (IL-1beta greatly enhanced IgE-dependent production of these cytokines in response to FcepsilonRI cross-linkage, suggesting a role for bystander/phagocytic cells in modulating mast cell function. In contrast, interferon-alpha (IFN-alpha) inhibited IL-5 and GM-CSF generation, and the glucocorticoid, dexamethasone (Dex), inhibited production of IL-5 and GM-CSF from CBDMC. A macrophage-mast cell-eosinophil axis may exist in vivo that may be susceptible to pharmacologic manipulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034046     DOI: 10.1089/107999002753675811

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  4 in total

1.  Regulation and dysregulation of immunoglobulin E: a molecular and clinical perspective.

Authors:  Mariah B Pate; John Kelly Smith; David S Chi; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2010-02-23

2.  Severe asthma and the omalizumab option.

Authors:  Christopher Wt Miller; Narayanaswamy Krishnaswamy; Chambless Johnston; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2008-05-20

Review 3.  Telangiectasia macularis eruptiva perstans: more than skin deep.

Authors:  Casey E Watkins; Winston B Bokor; Stuart Leicht; George Youngberg; Guha Krishnaswamy
Journal:  Dermatol Reports       Date:  2011-07-29

4.  MAPK-dependent regulation of IL-1- and beta-adrenoreceptor-induced inflammatory cytokine production from mast cells: implications for the stress response.

Authors:  David S Chi; S Matthew Fitzgerald; Shannon Pitts; Karen Cantor; Ellis King; Steven A Lee; Shau-Ku Huang; Guha Krishnaswamy
Journal:  BMC Immunol       Date:  2004-09-21       Impact factor: 3.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.